Whitepaper: Current Strategies for Enhancing Bioavailability of Poorly Soluble Compounds: A Discussion on Commonly Used Technologies & Supporting Services

Authors: Michelle Gischewski, Scientific Advisor, Drug Product Operations at Eurofins CDMO Alphora Inc.

Targeted bioavailability enhancement strategies can help improve the success of early drug candidates by maximizing the API’s exposure in early in-vivo studies. This whitepaper discusses commonly used technologies & supporting services that can help enhance bioavailability of poorly soluble compounds.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.


  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the phone number you would like to be contacted at.

  • Please enter the e-mail address you would like to be contacted at.


  • By submitting this form, you consent to Pharmaceutical Outsourcing storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.